Hope for Alzheimer's patients as PharmaKure files trial application
Clinical stage pharma company PharmaKure believe their combined drug targeting amyloid deposits associated with Alzheimer’s Disease can bring quality of life to patients.
Clinical stage pharma company PharmaKure believe their combined drug targeting amyloid deposits associated with Alzheimer’s Disease can bring quality of life to patients.
Traditionally, the pharmaceutical landscape has been dominated by small molecules.
Provider of solutions for computer-aided drug design (CADD), Cresset, says it has ambitions plans to scale up international operations.